Oncology & Cancer

Cancer cells co-opt immune response to escape destruction

Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.

Oncology & Cancer

New colorectal cancer targeted therapy combination shows promise

New SWOG study results show significantly better outcomes for patients with a treatment-resistant form of metastatic colorectal cancer when the BRAF inhibitor vemurafenib is added to a standard treatment. The findings, for ...

page 12 from 40